Javascript must be enabled to continue!
Clinical Efficacy of Chinese Medicine in Treating Adult Henoch–Schönlein Purpura: A Meta‐Analysis
View through CrossRef
Introduction
This meta‐analysis evaluates the efficacy of traditional Chinese medicine, alone or in combination with Western medicine, for the treatment of adult Henoch–Schönlein purpura.
Methods
We searched clinical randomized controlled trials on the treatment of adult Henoch–Schönlein purpura with traditional Chinese medicine from the Chinese Journal Literature Database (CNKI), Wanfang Database, Embase, PubMed, Cochrane, Scopus, the Journal of Pharmacopuncture, and the National Library of China. After removing duplicate literature and reviewing titles, we selected the final studies based on our inclusion and exclusion criteria. These studies were assessed for bias using the Cochrane risk of bias assessment tool, and statistical analysis was performed using Review Manager 5.3.0 software. The PRISMA guidelines were followed when conducting the meta‐analysis.
Results
Eighteen studies were included, with a combined sample size of 1632 cases, including 811 in the experimental group and 821 in the control group. The results indicated that traditional Chinese medicine, whether used alone or in combination with Western medicine, was more effective than Western medicine alone in terms of overall effectiveness and improvement in skin purpura, digestive tract, and joint symptoms. We found that the total clinical effective rate of patients in the experimental group was higher than that of the control group (OR = 6.04, 95% CI [4.01, 9.10],
p
< 0.001). Meta‐analysis indicates that the difference between the control and experimental groups in improving skin purpura symptoms is statistically significant (SMD = −1.09, 95% CI [−1.22, −0.96],
p
< 0.001). We found that a more significant improvement occurred in the experimental group than in the control group (SMD = −0.95, 95% CI [−1.08, −0.82],
p
< 0.001). People in the experimental group showed a greater decrease in joint symptoms than those in the control group (SMD = −0.95, 95% CI [−1.08, −0.82],
p
< 0.001).
Conclusion
Traditional Chinese medicine, either alone or combined with Western medicine, is more effective than Western medicine alone in treating Henoch–Schönlein purpura. It also shows superior efficacy in improving skin purpura, digestive tract, and joint symptoms.
Title: Clinical Efficacy of Chinese Medicine in Treating Adult Henoch–Schönlein Purpura: A Meta‐Analysis
Description:
Introduction
This meta‐analysis evaluates the efficacy of traditional Chinese medicine, alone or in combination with Western medicine, for the treatment of adult Henoch–Schönlein purpura.
Methods
We searched clinical randomized controlled trials on the treatment of adult Henoch–Schönlein purpura with traditional Chinese medicine from the Chinese Journal Literature Database (CNKI), Wanfang Database, Embase, PubMed, Cochrane, Scopus, the Journal of Pharmacopuncture, and the National Library of China.
After removing duplicate literature and reviewing titles, we selected the final studies based on our inclusion and exclusion criteria.
These studies were assessed for bias using the Cochrane risk of bias assessment tool, and statistical analysis was performed using Review Manager 5.
3.
0 software.
The PRISMA guidelines were followed when conducting the meta‐analysis.
Results
Eighteen studies were included, with a combined sample size of 1632 cases, including 811 in the experimental group and 821 in the control group.
The results indicated that traditional Chinese medicine, whether used alone or in combination with Western medicine, was more effective than Western medicine alone in terms of overall effectiveness and improvement in skin purpura, digestive tract, and joint symptoms.
We found that the total clinical effective rate of patients in the experimental group was higher than that of the control group (OR = 6.
04, 95% CI [4.
01, 9.
10],
p
< 0.
001).
Meta‐analysis indicates that the difference between the control and experimental groups in improving skin purpura symptoms is statistically significant (SMD = −1.
09, 95% CI [−1.
22, −0.
96],
p
< 0.
001).
We found that a more significant improvement occurred in the experimental group than in the control group (SMD = −0.
95, 95% CI [−1.
08, −0.
82],
p
< 0.
001).
People in the experimental group showed a greater decrease in joint symptoms than those in the control group (SMD = −0.
95, 95% CI [−1.
08, −0.
82],
p
< 0.
001).
Conclusion
Traditional Chinese medicine, either alone or combined with Western medicine, is more effective than Western medicine alone in treating Henoch–Schönlein purpura.
It also shows superior efficacy in improving skin purpura, digestive tract, and joint symptoms.
Related Results
Posterior reversible encephalopathy syndrome as a complication of Henoch–Schönlein purpura in a seven-year-old girl
Posterior reversible encephalopathy syndrome as a complication of Henoch–Schönlein purpura in a seven-year-old girl
Introduction
Henoch–Schönlein purpura is a multisystem small vessel vasculitis. Neurologic manifestations are uncommon. Posterior reversible encephalopathy synd...
Henoch-Schonlein Purpura (HSP)
Henoch-Schonlein Purpura (HSP)
Abstract—Henoch-Schonlein purpura (HSP) is a systemic vasculitic disease (vascular inflammation) characterized by the deposition of immune complexes consisting of IgA in kidney ski...
AGE RELATED CHARACTERISTICS OF CHILDREN AND ADOLESCENT WITH HENOCH SCHÖNLEIN PURPURA AND SYSTEMS INVOLVEMENT: AN EXPERIENCE FROM TERTIARY CARE CENTER
AGE RELATED CHARACTERISTICS OF CHILDREN AND ADOLESCENT WITH HENOCH SCHÖNLEIN PURPURA AND SYSTEMS INVOLVEMENT: AN EXPERIENCE FROM TERTIARY CARE CENTER
Background: Henoch-Schönlein Purpura (HSP) is the most common vasculitis among children and adolescent characterized by skin, joints, renal and gastrointestinal involvement. There ...
Henoch-Schonlein Purpura in Children at Department of Pediatric, Bach Mai Hospital
Henoch-Schonlein Purpura in Children at Department of Pediatric, Bach Mai Hospital
Objectives: To identify the percentage of parents having the correct knowledge of caring their children and evaluable quality of life in children with chronic kidney diseases. Subj...
Impaired In-vitro Platelet Aggregation and Secretion Tests in Children with Henoch-schöenlein Purpura
Impaired In-vitro Platelet Aggregation and Secretion Tests in Children with Henoch-schöenlein Purpura
Abstract Aim: This study aimed to investigate the in-vitro platelet
aggregation and secretion tests in children patients with
Henoch-schöenlein Purpura that recently referred to as...
Nefritis Purpura Henoch Schonlein
Nefritis Purpura Henoch Schonlein
Nefritis Henoch-Schonlein adalah purpura Henoch Schonlein (PHS) dengan keterlibatan ginjal. Manifestasinefritis Henoch-Schonlein antara lain hematuria mikroskopik, hematuria makros...
Gastrointestinal Dominant Henoch Schönlein Purpura in Children: A Report of Two Cases
Gastrointestinal Dominant Henoch Schönlein Purpura in Children: A Report of Two Cases
Background: Henoch Schönlein Purpura (HSP) is the most common vasculitis in children, characterized by purpura, arthritis, gastrointestinal involvement, and nephritis. Gastrointest...
Henoch-Schönlein Purpura in Children: An Updated Review
Henoch-Schönlein Purpura in Children: An Updated Review
Background:
Henoch-Schönlein purpura (HSP) is an IgA-mediated systemic smallvessel
vasculitis with a predilection for the skin, gastrointestinal tract, joints, and kidneys. It is t...

